Best MDRO surveillance software for community hospitals, matched to the four MDRO metrics your program actually reports
Most MDRO software decisions go wrong because the hospital buys for the metric it does not have trouble with. Here is the shortlist sorted by the four MDRO metrics SHEA and HICPAC recommend, what each product covers, and which one a 100 to 300 bed hospital actually needs.
9 min read
The best MDRO surveillance software for a community hospital depends on which MDRO job is failing today. If infection prevention cannot flag returning MRSA or CRE patients for isolation, you need a patient-level surveillance platform such as Sentri7 Infection Prevention, Inovalon's VigiLanz infection prevention suite, Premier's TheraDoc, BD HealthSight Infection Advisor, or Epic Bugsy. If the gap is facility-level resistance trends and the antibiogram, a lab-based tool that works from your susceptibility export does that for a published $749 a month, with no interface project.
This guide is for the infection prevention director, the stewardship pharmacist and the quality or pharmacy director at a 100 to 300 bed US hospital who has been asked to "get MDRO surveillance software". Vendors are described only from their own product pages. None of the enterprise platforms publishes a price.
Start with the four MDRO metrics, not the vendor list
The SHEA and HICPAC position paper on MDRO metrics (Cohen and colleagues, Infection Control and Hospital Epidemiology, 2008) is still the reference most programs follow. It recommends four routine metrics: an MDRO-specific line list of patients, an antibiogram for susceptibility patterns, the incidence of hospital-onset MDRO bacteremia, and clinical culture results to measure how many patients acquire an MDRO in the facility. Hospital onset means the specimen was collected more than three calendar days after admission, the "3 midnight rule". The paper also says the metrics should not be used to compare facilities with each other.
The line list and the antibiogram are the two it calls basic, for every facility in all circumstances. CDC's MDRO guideline says the same in practical terms: prepare facility-specific susceptibility reports as CLSI recommends, and monitor trends in the incidence of target MDROs over time to see whether rates are falling.
Those four metrics split cleanly into two kinds of software. The line list and the hospital-onset metrics need patient-level data with admission dates and locations, which means an EHR feed. The antibiogram and resistance trends need only the lab's susceptibility results. Buying one platform to do both is the common choice at large hospitals, and the common mistake at small ones.
MDRO surveillance software compared
The table lists the realistic options for a US community hospital, grouped by the metric each one is built around. "Not published" means the vendor does not list a price, which is normal for enterprise clinical software.
| Option | Built around | Patient line list and isolation | NHSN reporting | Price published |
|---|---|---|---|---|
| Sentri7 Infection Prevention (Wolters Kluwer) | Real-time HAI and MDRO surveillance from the EHR | Yes, manages isolation protocols and LabID events | One-click NHSN submission | No |
| Inovalon infection prevention (VigiLanz) | Surveillance across labs, vitals, medications and notes | Yes, tracks HAIs and MDROs | Automated NHSN reporting | No |
| Premier clinical surveillance (TheraDoc) | Automated infection tracking for hospitals and long-term care | Yes, standardized IP workflows | Automated NHSN reporting tools | No |
| BD HealthSight Infection Advisor (MedMined) | Hosted HAI surveillance and cluster detection against a baseline | HAI focused; no MDRO isolation flags stated | Automated HAI reporting to NHSN | No |
| Epic Bugsy | Infection surveillance inside the Epic EHR | Yes, built by your Epic team | Reports to regulatory entities | Part of the Epic contract |
| NHSN MDRO/CDI module (CDC) | LabID event reporting for benchmarking | No, you enter or upload the events | It is NHSN | No license fee |
| Antimicrobe Stewardship | Antibiogram, resistance trends and MDRO rates from the lab export | No, facility-level counts only | No | $749 a month |
The surveillance platforms, one by one
Sentri7 Infection Prevention is the current category leader by the one public ranking that exists. Wolters Kluwer states that Best in KLAS ranked it first in 2026 for Infection Control and Monitoring, for the fourth time in five years. Its page describes proactive surveillance that flags at-risk patients, management of isolation protocols, LabID event analysis, one-click NHSN submission and integration with your EHR.
Inovalon's infection prevention product, which grew out of VigiLanz, pulls from labs, vitals, medications and notes, and is described for tracking HAIs, MDROs or construction-related risks, with NHSN reports that go directly to NHSN. Premier sells clinical surveillance powered by TheraDoc for hospitals and long-term care, with automated NHSN reporting tools and a direct EHR connection; Premier's own headline claim is that automated infection tracking cuts daily surveillance time by 40 percent.
BD HealthSight Infection Advisor with MedMined Insights is a hosted HAI surveillance product. BD describes comparing the current incidence of isolates in a facility with a historic baseline to find anomalies and emerging clusters, using its Nosocomial Infection Marker. Epic hospitals already own Bugsy, which Epic describes as the application infection preventionists use to maintain surveillance, analyze infection trends and report when patients acquire infections during admission.
If BD is the platform you are leaving, the side-by-side is on MedMined and BD HealthSight alternatives. Pharmacy-side comparisons of the same vendors are in Sentri7 vs TheraDoc vs VigiLanz.
If your hospital runs Epic and is deciding whether Bugsy is enough, the 2026 KLAS scores and build effort are in Epic Bugsy alternatives.
Is MDRO surveillance software worth it for a small hospital?
It is worth it when manual review is eating infection prevention hours that the hospital cannot replace. A systematic review of electronic surveillance (Russo and colleagues, Journal of Hospital Infection, 2018) found that 13 of 16 studies showed less infection preventionist time spent on surveillance, with reductions between 12.5 and 98.4 percent, and none showed an increase. That is the case for a platform at a hospital with a full-time IP team and a steady MDRO census.
At a 100 bed hospital with one infection preventionist, the arithmetic changes. The EHR usually already flags known MDRO patients on readmission, NHSN LabID reporting for MRSA bacteremia and C. difficile is a monthly task, and what nobody has time for is the annual antibiogram and a quarterly look at whether ESBL or CRE rates are moving. Paying enterprise platform prices, plus an interface project, to fix that last piece is poor value.
What the NHSN MDRO module does and does not give you
The CDC NHSN MDRO and CDI module is where hospitals report LabID events for MRSA, VRE, cephalosporin-resistant Klebsiella, CRE, multidrug-resistant Acinetobacter and C. difficile. The January 2026 protocol defines a healthcare facility-onset event as a specimen collected on hospital day 4 or later, and standardized infection ratios exist only for facility-wide inpatient MRSA bacteremia and C. difficile.
That makes NHSN a benchmarking and reporting system, not surveillance software. It will not tell you that ceftriaxone resistance in your E. coli rose from 12 to 19 percent over three quarters, and it does not produce the facility antibiogram CDC's MDRO guideline asks for. Most community hospitals need something beside it for that.
Where a lab-based tool fits
Antimicrobe works from the susceptibility CSV your lab already exports. From one file it builds the CLSI M39 antibiogram and counts six MDRO phenotypes each quarter: MRSA, VRE, third-generation cephalosporin resistant Enterobacterales, CRE, carbapenem-resistant Pseudomonas and carbapenem-resistant Acinetobacter. Each rate is the share of first isolates tested against the marker agent that the lab reported resistant, and any quarter with fewer than 30 isolates is marked as too few rather than shown as a percentage.
On the Stewardship plan you set a threshold for each phenotype, and the seats on the plan get an email when a quarter crosses it. That covers the antibiogram and the trend part of the SHEA and HICPAC metrics. It does not replace a line list: there are no patient names, no admission dates and no isolation flags, so hospital-onset rates and isolation stay with your EHR or your platform.
How the six phenotypes are defined, and how CRE is tracked by unit, is on carbapenem-resistant organism tracking. The wider category, including how it differs from pharmacy alerting, is covered on antimicrobial resistance surveillance software.
How much does MDRO surveillance software cost?
Enterprise surveillance platforms do not publish prices. Expect a one-time implementation fee, an annual license and an interface build between the platform and your EHR and lab system, plus the IT hours to maintain it. The honest way to compare is to ask each vendor for a three-year total including the interface.
Antimicrobe publishes its prices. MDRO watch and threshold alerts are on the Stewardship plan at $749 a month for up to 3 facilities, 150,000 isolates a year and 8 seats. The Lab plan at $249 a month builds the antibiogram without the MDRO watch. There is no implementation fee on either.
A route-by-route cost comparison is in how much antibiogram software costs, and every plan limit is on the pricing page.
Which option fits which hospital
- Over 300 beds, a full IP team, and no electronic surveillance today: shortlist Sentri7, Inovalon and Premier, and ask each for a three-year total with the interface
- On Epic with analysts who have time: build in Bugsy first, and measure what it still leaves on paper
- Already on a platform but the antibiogram is still built by hand: keep the platform and move the antibiogram and trend work to a lab-based tool
- Under 200 beds with one infection preventionist: EHR MDRO flags plus NHSN LabID for reporting, and a lab-based tool for the antibiogram and quarterly MDRO rates
- Microbiology outsourced to a reference lab: CDC's guideline says to write facility-specific susceptibility data into the lab contract. Ask for the line-level export, then build from it
Questions to ask on a demo
- Which of the four SHEA and HICPAC metrics does the product produce without manual work, and which need an analyst?
- Is the MDRO rate built on first isolates, and can we see the denominator?
- Does the antibiogram follow CLSI M39, including suppression under 30 isolates?
- What does the interface need from our EHR and lab system, and who maintains it after an upgrade?
- What is the three-year total, including implementation and interface fees?
The quarterly numbers usually end up on slides for the infection control committee, and a tool that can turn a report into a presentation deck saves the last hour of that job.
If that hour matters, a presentation maker that builds slides from your reports handles it. For the antibiogram side, the builder at the top of this page runs on sample data, and CLSI M39 antibiogram software explains the rules it applies.
Related on this site: carbapenem-resistant organism tracking, infection prevention software, best antimicrobial stewardship software for community hospitals, MedMined and BD HealthSight alternatives.